30.10.2013 Views

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Genetic analysis, linkage, and association<br />

ity and find novel loci for the MetS (IDF, 2003) and correlate inflammation<br />

and visceral obesity with MetS, in a Dutch isolate.<br />

Methods: The Erasmus Rucphen Family study (ERF) consists of some<br />

3000 individuals that descend form a limited set of founders. Waist circumference<br />

(WC), blood pressure, HDL-C, triglycerides and glucose<br />

levels were obtained. Variance component analysis was applied to extended<br />

family data to test for evidence of heritability (SOLAR).<br />

Results: The prevalence of MetS, according to the IDF definition, in<br />

the ERF cohort is 36.8% in males and 31.0% in females. Our results<br />

indicate that HDL-C and WC are the main contributors to the MetS.<br />

Heritability of the MetS (as binary trait) was 14.3% (P < 0.0001). The<br />

heritability for the MetS corrected for household, decreased to 10.6%<br />

(P = 0.012). Also the heritability of individual components of MetS were<br />

analyzed (as quantative traits). The highest heritability was obtained<br />

for HDL-C (42.9%, P < 0.0001).<br />

Discussion: The heritabilities of MetS in the ERF population are found<br />

to be highly significant. Moreover, our results indicate that the HDL-C<br />

component is a main contributor to the MetS and was found to have<br />

the highest individual heritability. Our data on prevalence and heritability<br />

of the MetS, indicate that determining loci for MetS by linkage<br />

analysis, with emphasis on the individual traits, is feasible.<br />

P1024. Homozygous silencing of the T-box transcription factor<br />

TBR2/EOMES locus. Results in a microcephaly syndrome with<br />

polymicrogyria and corpus callosum agenesis<br />

L. Baala 1,2 , S. Briault 3 , H. C. Etchevers 2 , F. Laumonnier 3 , A. Natiq 1 , J. Amiel 2 ,<br />

N. Boddaert 4 , C. Picard 5 , A. Sbiti 1 , A. Asermouh 6 , T. Attié-Bitach 2,7 , F. Encha-<br />

Razavi 2,7 , A. Munnich 2,7 , A. Sefiani 1 , S. Lyonnet 2,7 ;<br />

1 Dép. Génétique Médicale, Institut National d’Hygiène, Rabat, Morocco,<br />

2 INSERM U-781, Hôpital Necker-Enfants Malades (AP-HP), Paris, France,<br />

3 INSERM U-6<strong>19</strong> Faculté de Médecine, Tours, France, 4 Service de Radiologie<br />

Pédiatrique, Hôpital Necker-Enfants Malades (AP-HP), Paris, France, 5 Centre<br />

d’étude des Déficits Immunitaires, Hôpital Necker-Enfants Malades (AP-HP),<br />

Paris, France, 6 Hôpital d’Enfants Avicenne, Rabat, Morocco, 7 Université René<br />

Descartes, Paris, France.<br />

Mechanisms regulating brain size during neurogenesis include the<br />

regulation of neural progenitor proliferation and migration. We report<br />

an autosomal recessive microcephaly syndrome co-segregating with<br />

a homozygous balanced translocation between chromosomes 3p and<br />

10q in a large inbred family. The translocation was found at the homozygous<br />

status in all affected individuals (46,XY,t(3;10)(p24;q23)2x),<br />

while unaffected parents were heterozygous. We established a physical<br />

and characterized the BACs that encompassed the breakpoints on<br />

3p24 and 10q23 (BAC RP11-9a14 and RP11-104H24). Interestingly,<br />

neither of the two translocation breakpoints disrupted a known or predicted<br />

gene coding sequence.<br />

However, we showed that a position effect at the breakpoint on chromosome<br />

3 silences the Tbox-brain2/Eomesodermin (TBR2/EOMES)<br />

transcript. Together with its expression pattern in the developing human<br />

brain, our data suggest an involvement of TBR2/EOMES in neuronal<br />

division and/or migration. Thus, mutations in not only mitotic and<br />

apoptotic proteins but also transcription factors may be responsible for<br />

malformative microcephaly syndromes.<br />

P1025. Identification of a gene involved in hereditary microcytic<br />

anemia due to defective iron absorption in a Sardinian family<br />

M. A. Melis 1 , M. Cau 1 , R. Congiu 1 , G. Sole 2 , A. Cao 2 , R. Galanello 1 ;<br />

1 University of Cagliari, Cagliari, Italy, 2 CNR, Cagliari, Italy.<br />

We report the study of a large sardinian family where five patients<br />

show iron deficiency resulting in microcytic hypochromic anemia, not<br />

responsive to oral treatment but partially responsive to parenteral treatment.<br />

Known causes of hereditary microcytic anemia such as thalassemia,<br />

hemorrages, gastrointestinal disorders have been excluded by<br />

specific tests. By the pedigree analysis it seems an autosomal recessive<br />

disorder. Since clinical data suggest that it could be a defect of<br />

iron metabolism, especially a defect of iron absorption and/or mobilization<br />

of intracellular iron storage, initially we studied all the known gene<br />

involved in iron metabolism (Tf, TfR, ZIRTL, HJV and DMT1). Linkage<br />

analysis for these genes resulted negative, therefore we supposed<br />

that a different gene could be involved. Wide genome screening using<br />

300 microsatellite markers was performed and a chromosome 22q13<br />

region showing 5.6 multipoint LOD SCORE near marker D22S1177<br />

and 5.4 multipoint LOD SCORE near marker D22S423. This region<br />

2 1<br />

spans 7.2 cM and the affected subjects share two homozygous tracts.<br />

No recombination has been observed.<br />

A further linkage analysis based on SNPs study was performed to better<br />

define the locus limits. This study confirmed the homozygous tract<br />

but did not allow to narrow the interval of interest. These results reinforce<br />

the hypotesis that the locus for hereditary microcytic anemia is<br />

on chromosome 22q13.<br />

The 7.2 cM critical region of chromosome has been completely sequenced<br />

and is available from published databases. A large number of<br />

genes have already been characterized in the region.<br />

P1026. Exclusion of ADAMTS10 gene for the isolated<br />

microspherophakia in a consanguineous multiplex Tunisian<br />

family<br />

F. Ouechtati 1 , S. Ben Yahia 2 , I. Chouchen 1 , S. Chakroun 1 , M. Kheirallah 2 , S.<br />

Abdelhak 1 ;<br />

1 UR26/04 Molecular investigation of genetic orphan diseases, Pasteur Institute<br />

of Tunis, Tunis, Tunisia, 2 Department of Ophthalmology, Fattouma Bourguiba<br />

Hospital, Monastir, Tunisia.<br />

Microspherophakia (OMIM 251750) is an eye disease characterized<br />

by a small and spherical crystalline lens with increased anteroposterior<br />

thickness. Autosomal recessive Weill Marchesani Syndrome is<br />

due to mutations within ADAMTS10 gene. The locus responsible for<br />

the isolated form of microspherophakia is still unknown because the<br />

reported cases are rare and sporadic. A consanguineous family with<br />

two patients affected with isolated microspherophakia has been identified<br />

in Central Tunisia. In order to check if ADAMTS10 gene is involved<br />

in microspherophakia in this family, a linkage analysis was performed<br />

using microsatellite markers flanking this gene. Genetic investigation<br />

showed an exclusion of linkage between ADAMTS10 gene and the<br />

disease locus in this family. This result suggests that isolated microspherophakia<br />

is not an allelic disorder to Weill Marchesani Syndrome.<br />

P1027. Mitochondrial mutations in maternally-inherited nonsyndromic<br />

deafness: whole-mitochondrial-genome screening<br />

using a microarray resequencing mitochondrial DNA chip<br />

M. Leveque 1 , S. Marlin 1 , L. Jonard 1 , V. Procaccio 2 , P. Reynier 3 , S. Baulande 4 ,<br />

R. Couderc 1 , E. Garabedian 1 , C. Petit 5 , D. Feldmann 1 , F. Denoyelle 1 ;<br />

1 AP-HP, Trousseau, Paris, France, 2 Université de Califormie, Irvine, CA, United<br />

States, 3 INSERM U688, Angers, France, 4 PartnerChip, Evry, France, 5 INSERM<br />

U587, Institut Pasteur, Paris, France.<br />

Mitochondrial DNA (mtDNA) mutations have been implicated in nonsyndromic<br />

hearing loss, with various degrees of penetrance. As only<br />

part of the mitochondrial genome is usually explored in deaf patients,<br />

their prevalence is probably under-estimated. Among 1350 families<br />

with sensorineural deafness collected through a French collaborative<br />

network, we selected 29 large families with clear maternal inheritance<br />

and screened them for the known mtDNA mutations in 12S rRNA,<br />

tRNAser(UCN), and tRNAleu(UUN) genes. When no mutation could<br />

be identified, a whole-mitochondrial genome screen was performed<br />

using the MitoChip v2.0 microarray resequencing chip (Affymetrix,<br />

Inc). Known mtDNA mutations were found in 9 of the 29 families:<br />

A1555G in five, T7511C in two, 7472insC and A3243G in one each.<br />

In the remaining 20 families, the resequencing Mitochip detected 258<br />

mitochondrial homoplasmic variants and 107 potentially heteroplasmic<br />

variants. The more likely pathogenic variants are displayed based on<br />

allelic frequency and conservation between species. The whole-genome<br />

analysis elicited 5 additional families with a possibly pathogenic<br />

mitochondrial DNA variant: T669C, C1537T, G8078A, G12236A, and<br />

G15077A. These results indicate that the new MitoChip platform is a<br />

rapid and reliable tool for (the) identification of new mtDNA mutations,<br />

whether in deafness or other mtDNA-related diseases.<br />

P1028. Multiple Ligation Probe Amplification analysis in the DMD<br />

gene: hidden results<br />

M. Rodriguez, J. Juan, L. Gonzalez-Quereda, S. Gutierrez, M. Baiget, P. Gallano;<br />

<strong>Genetics</strong> Dept, Hospital de Sant Pau, Barcelona, Spain.<br />

Duchenne and Becker muscular dystrophies (DMD/BMD) are the<br />

most common form of dystrophinopathies, with a reported incidence of<br />

1:3500 and 1:18000 birth males repectively.<br />

About 65% of DMD/BMD cases are attributable to large deletions of<br />

the DMD gene, whereas the remaining cases are caused by duplica-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!